STAT3 and ovarian carcinoma: Inhibition of STAT3 with AG490 followed by treatment with cisplatin or paclitaxel resulted in a significant increase in apoptosis, suggesting that hypoxia-induced activation of STAT3 is associated with chemotherapy resistance, suggesting that STAT3 has a tendency to promote drug resistance in ovarian cancer [21].